Trupanion, Inc. (NASDAQ:TRUP) SVP Sells $49,095.00 in Stock

Trupanion, Inc. (NASDAQ:TRUP) SVP Emily Dreyer sold 900 shares of the stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $54.55, for a total transaction of $49,095.00. Following the completion of the transaction, the senior vice president now directly owns 23,808 shares of the company’s stock, valued at approximately $1,298,726.40. The trade was a 3.64 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Emily Dreyer also recently made the following trade(s):

• On Friday, November 22nd, Emily Dreyer sold 3,100 shares of Trupanion stock. The stock was sold at an average price of $54.85, for a total transaction of $170,035.00.

Trupanion Price Performance

NASDAQ TRUP opened at $53.50 on Friday. The firm’s fifty day simple moving average is $49.73 and its two-hundred day simple moving average is $40.06. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.40. Trupanion, Inc. has a 12-month low of $19.69 and a 12-month high of $57.90. The firm has a market capitalization of $2.27 billion, a P/E ratio of -167.19 and a beta of 1.69.

Trupanion (NASDAQ:TRUP) last posted its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $0.03 EPS for the quarter, topping the consensus estimate of ($0.06) by $0.09. Trupanion had a negative net margin of 1.08% and a negative return on equity of 4.36%. The business had revenue of $327.50 million during the quarter, compared to the consensus estimate of $321.79 million. During the same period in the previous year, the firm posted ($0.10) earnings per share. The business’s revenue for the quarter was up 14.6% compared to the same quarter last year. Analysts forecast that Trupanion, Inc. will post -0.23 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

TRUP has been the subject of several analyst reports. Evercore ISI raised shares of Trupanion to a “strong-buy” rating in a research note on Friday, August 9th. Bank of America raised their price objective on shares of Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a research note on Friday, September 20th. Piper Sandler raised their price objective on shares of Trupanion from $45.00 to $57.00 and gave the stock a “neutral” rating in a research note on Thursday, October 31st. Stifel Nicolaus raised their price objective on shares of Trupanion from $30.00 to $40.00 and gave the stock a “hold” rating in a research note on Monday, September 23rd. Finally, Northland Securities raised their target price on shares of Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a research report on Thursday, October 31st. Three research analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $44.67.

Institutional Investors Weigh In On Trupanion

Several institutional investors and hedge funds have recently made changes to their positions in TRUP. Quest Partners LLC acquired a new stake in shares of Trupanion during the third quarter worth $37,000. Wilmington Savings Fund Society FSB acquired a new position in Trupanion during the third quarter valued at $54,000. GAMMA Investing LLC lifted its position in Trupanion by 70.4% during the third quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider’s stock valued at $61,000 after purchasing an additional 596 shares during the period. Headlands Technologies LLC acquired a new position in Trupanion during the second quarter valued at $162,000. Finally, Entropy Technologies LP acquired a new position in Trupanion during the third quarter valued at $202,000.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.